Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May;120(5):472-477.
doi: 10.1007/s00347-023-01854-0. Epub 2023 Apr 24.

[Clinical aspects of ocular mucosal pemphigoid]

[Article in German]
M Roth  1 , R Yaici  2 , G Geerling  2
Affiliations
Review

[Clinical aspects of ocular mucosal pemphigoid]

[Article in German]
M Roth et al. Ophthalmologie. 2023 May.

Abstract
in English, German

Mucosal pemphigoid is a rare chronic autoimmune disease that also affects the eyes in more than two thirds of all cases. Especially in the early phase of the ocular manifestation, the findings are subtle and the disease is often not recognized. The aim of this article is to provide the clinical aspects of ocular mucosal pemphigoid so that timely diagnostics can be initiated when this disease is suspected.

Das Schleimhautpemphigoid ist eine seltene, chronische Autoimmunerkrankung, die in mehr als zwei Drittel aller Fälle auch die Augen betrifft. Insbesondere in der Frühphase der okulären Manifestation sind die Befunde dezent, und die Erkrankung wird häufig nicht erkannt. Ziel dieses Beitrages ist, die Klinik des okulären Schleimhautpemphigoids zu vermitteln, sodass bei Verdacht auf diese Erkrankung frühzeitig die Diagnostik eingeleitet werden kann.

Keywords: Ankyloblepharon; Autoimmune disease; Ocular manifestation; Scarring conjunctivitis; Symblepharon.

PubMed Disclaimer

Similar articles

See all similar articles

References

Literatur

    1. van Beek N, Zillikens D, Schmidt E (2021) Bullous autoimmune dermatoses: clinical features, diagnostic evaluation, and treatment options. Dtsch Arztebl Int 118:413–420. https://doi.org/10.3238/arztebl.m2021.0136 - DOI - PubMed - PMC
    1. Amber KT, Murrell DF, Schmidt E et al (2018) Autoimmune subepidermal bullous diseases of the skin and mucosae: Clinical features, diagnosis, and management. Clin Rev Allergy Immunol 54:26–51. https://doi.org/10.1007/s12016-017-8633-4 - DOI - PubMed
    1. Rashid H, Lamberts A, Borradori L et al (2021) European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.17397 - DOI - PubMed - PMC
    1. S2k-Leitlinie Diagnostik und Therapie des Schleimhautpemphigoid. AWMF-Register-Nr: 013-102, 2022
    1. Bertram F, Bröcker E, Zillikens D, Schmidt E (2009) Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. JDDG 7:434–439. https://doi.org/10.1111/j.1610-0387.2008.06976.x - DOI - PubMed

LinkOut - more resources